Advertisement

Index by author

December 01, 1985; Volume 235,Issue 3

A

  1. Abel, P W

    1. Thyroid status and adrenergic receptor subtypes in the rat: comparison of receptor density and responsiveness.
      A W Fox, E N Juberg, J M May, R D Johnson, P W Abel and K P Minneman
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 715-723;

  2. Aceto, J F

    1. Measurement of thermodynamic parameters for norepinephrine contraction of isolated rabbit thoracic aorta.
      R B Raffa, J F Aceto and R J Tallarida
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 596-600;

  3. Anders, M W

    1. Nephrotoxicity of S-(2-chloro-1,1,2-trifluoroethyl)glutathione and S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine, the glutathione and cysteine conjugates of chlorotrifluoroethene.
      D R Dohn, J R Leininger, L H Lash, A J Quebbemann and M W Anders
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 851-857;

  4. Antrim, L

    1. Relationship between Ah receptor-mediated polychlorinated biphenyl (PCB)-induced humoral immunosuppression and thymic atrophy.
      J B Silkworth and L Antrim
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 606-611;

  5. Arnsdorf, M F

    1. Electrophysiologic actions and interactions between lysophosphatidylcholine and lidocaine in the nonsteady state: the match between multiphasic arrhythmogenic mechanisms and multiple drug effects in cardiac Purkinje fibers.
      G J Sawicki and M F Arnsdorf
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 829-838;

B

  1. Baker, T

    1. Pharmacologic excitability of rat motor nerve endings: the effect of adrenalectomy on neostigmine-induced fasciculations.
      J S Sprouse, T Baker and W F Riker
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 864-872;

  2. Barrett, D A

    1. Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists.
      K A Neve, D A Barrett and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 657-664;

  3. Berry, R G

    1. Effects of ethyl alcohol on phasic and tonic contractions of the proximal stomach.
      K M Sanders and R G Berry
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 858-863;

  4. Blumberg, A L

    1. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
      R J Shebuski, T Fujita, J M Smith, L J Kopaciewicz, A L Blumberg and J P Hieble
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 735-740;

  5. Bunting, P B

    1. Blockade of endothelium-dependent relaxation by the amiloride analog dichlorobenzamil: possible role of Na+/Ca++ exchange in the release of endothelium-derived relaxant factor.
      R J Winquist, P B Bunting and T L Schofield
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 644-650;

  6. Burch, R M

    1. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
      D E Mais, R M Burch, D L Saussy, P J Kochel and P V Halushka
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 729-734;

C

  1. Caldwell, R W

    1. Effect of an aminocardenolide and digoxin upon atrioventricular refractory period in the dog.
      R W Caldwell and C B Nash
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 583-588;

  2. Cavero, I

    1. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
      I Cavero, J Lorrain, E D Di Paola, F Lhoste, B Payen, T Dennis and B Scatton
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 798-809;

  3. Chisolm, J J

    1. Use of 2,3-dimercaptopropane-1-sulfonate in treatment of lead poisoning in children.
      J J Chisolm and D J Thomas
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 665-669;

  4. Clineschmidt, B V

    1. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
      B V Clineschmidt, D R Reiss, D J Pettibone and J L Robinson
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 696-708;

  5. Coffin, V L

    1. Modulation of the behavioral effects of chlordiazepoxide by methylxanthines and analogs of adenosine in squirrel monkeys.
      V L Coffin and R D Spealman
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 724-728;

  6. Coffman, J D

    1. Beta adrenergic-mediated vasodilator response to insulin in the human forearm.
      M A Creager, C S Liang and J D Coffman
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 709-714;

  7. Collins, A C

    1. Time course study of the effects of chronic nicotine infusion on drug response and brain receptors.
      M J Marks, J A Stitzel and A C Collins
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 619-628;

  8. Creager, M A

    1. Beta adrenergic-mediated vasodilator response to insulin in the human forearm.
      M A Creager, C S Liang and J D Coffman
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 709-714;

D

  1. Da Silva, A M

    1. Comparative cardiorespiratory effects produced by taurine and glycine applied to the ventral surface of the medulla.
      P J Gatti, J D Souza, I J Namath, A M Da Silva, J R Holtman and R Gillis
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 820-828;

  2. Davis, J

    1. Acute tolerance development to the cardiovascular and subjective effects of cocaine.
      M W Fischman, C R Schuster, J Javaid, Y Hatano and J Davis
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 677-682;

  3. Dennis, T

    1. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
      I Cavero, J Lorrain, E D Di Paola, F Lhoste, B Payen, T Dennis and B Scatton
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 798-809;

  4. Di Paola, E D

    1. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
      I Cavero, J Lorrain, E D Di Paola, F Lhoste, B Payen, T Dennis and B Scatton
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 798-809;

  5. Dohn, D R

    1. Nephrotoxicity of S-(2-chloro-1,1,2-trifluoroethyl)glutathione and S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine, the glutathione and cysteine conjugates of chlorotrifluoroethene.
      D R Dohn, J R Leininger, L H Lash, A J Quebbemann and M W Anders
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 851-857;

  6. Dray, A

    1. Proenkephalin A fragments exhibit spinal and supraspinal opioid activity in vivo.
      A Dray, L Nunan and W Wire
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 670-676;

E

  1. Evans, R A

    1. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart.
      R A Evans, M Watson, H I Yamamura and W R Roeske
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 612-618;

F

  1. Farruggella, T

    1. Effect of netilmicin on the phospholipid composition of subcellular fractions of rat renal cortex.
      C Josepovitz, T Farruggella, R Levine, B Lane and G J Kaloyanides
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 810-819;

  2. Fischman, M W

    1. Acute tolerance development to the cardiovascular and subjective effects of cocaine.
      M W Fischman, C R Schuster, J Javaid, Y Hatano and J Davis
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 677-682;

  3. Fox, A W

    1. Thyroid status and adrenergic receptor subtypes in the rat: comparison of receptor density and responsiveness.
      A W Fox, E N Juberg, J M May, R D Johnson, P W Abel and K P Minneman
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 715-723;

  4. Fujii, K

    1. Effects of YM-12617, an alpha adrenoceptor blocking agent, on electrical and mechanical properties of the guinea-pig mesenteric and pulmonary arteries.
      K Fujii and H Kuriyama
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 764-770;

  5. Fujioka, M

    1. Eperisone, an antispastic agent, possesses vasodilating actions on the guinea-pig basilar artery.
      M Fujioka and H Kuriyama
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 757-763;

  6. Fujita, T

    1. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
      R J Shebuski, T Fujita, J M Smith, L J Kopaciewicz, A L Blumberg and J P Hieble
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 735-740;

G

  1. Gatti, P J

    1. Comparative cardiorespiratory effects produced by taurine and glycine applied to the ventral surface of the medulla.
      P J Gatti, J D Souza, I J Namath, A M Da Silva, J R Holtman and R Gillis
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 820-828;

  2. Gillis, R

    1. Comparative cardiorespiratory effects produced by taurine and glycine applied to the ventral surface of the medulla.
      P J Gatti, J D Souza, I J Namath, A M Da Silva, J R Holtman and R Gillis
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 820-828;

  3. Goodman, R R

    1. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
      E F Hahn, S Nishimura, R R Goodman and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 839-845;

  4. Goshima, Y

    1. Presynaptic inhibitory dopamine receptors on noradrenergic nerve terminals: analysis of biphasic actions of dopamine and apomorphine on the release of endogenous norepinephrine in rat hypothalamic slices.
      Y Misu, Y Goshima, H Ueda and T Kubo
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 771-777;

  5. Guild, S

    1. Pertussis toxin blocks somatostatin inhibition of calcium mobilization and reduces the affinity of somatostatin receptors for agonists.
      T Reisine and S Guild
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 551-557;

H

  1. Hahn, E F

    1. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
      E F Hahn, S Nishimura, R R Goodman and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 839-845;
    2. Irreversible opiate agonists and antagonists. III. Phenylhydrazone derivatives of naloxone and oxymorphone.
      E F Hahn, Y Itzhak, S Nishimura, N Johnson and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 846-850;

  2. Halushka, P V

    1. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
      D E Mais, R M Burch, D L Saussy, P J Kochel and P V Halushka
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 729-734;

  3. Hanin, I

    1. Regional differences in ethylcholine mustard aziridinium ion (AF64A)-induced deficits in presynaptic cholinergic markers for the rat central nervous system.
      T W Vickroy, M Watson, S M Leventer, W R Roeske, I Hanin and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 577-582;

  4. Hartz, R S

    1. Inhibition of electrogenic Na-pumping attributable to binding of cardiac steroids to high-affinity pump sites in human atrium.
      H H Rasmussen, R E Ten Eick, G T Okita, R S Hartz and D H Singer
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 629-635;

  5. Hatano, Y

    1. Acute tolerance development to the cardiovascular and subjective effects of cocaine.
      M W Fischman, C R Schuster, J Javaid, Y Hatano and J Davis
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 677-682;

  6. Heisler, S

    1. Stimulation of adrenocorticotropin secretion from AtT-20 cells by the calcium channel activator, BAY-K-8644, and its inhibition by somatostatin and carbachol.
      S Heisler
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 741-748;

  7. Hieble, J P

    1. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
      R J Shebuski, T Fujita, J M Smith, L J Kopaciewicz, A L Blumberg and J P Hieble
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 735-740;

  8. Holtman, J R

    1. Comparative cardiorespiratory effects produced by taurine and glycine applied to the ventral surface of the medulla.
      P J Gatti, J D Souza, I J Namath, A M Da Silva, J R Holtman and R Gillis
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 820-828;

  9. Hornsveld, R

    1. Effects of the renal vasodilator prodrug CGP 22 979A and its parent compound CGP 18 137A on renal and central hemodynamics in conscious spontaneously hypertensive rats.
      H M Nievelstein, H van Essen, R Hornsveld, H A Struyker-Boudier and J F Smits
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 778-782;

I

  1. Itoh, T

    1. Mechanisms of the bepridil-induced vasodilation of the rabbit mesenteric artery.
      H Suzuki, T Itoh and H Kuriyama
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 749-756;

  2. Itoh, Y

    1. Phencyclidine and the dynamics of mouse brain histamine.
      Y Itoh, R Oishi, M Nishibori and K Saeki
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 788-792;

  3. Itzhak, Y

    1. Irreversible opiate agonists and antagonists. III. Phenylhydrazone derivatives of naloxone and oxymorphone.
      E F Hahn, Y Itzhak, S Nishimura, N Johnson and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 846-850;

J

  1. Javaid, J

    1. Acute tolerance development to the cardiovascular and subjective effects of cocaine.
      M W Fischman, C R Schuster, J Javaid, Y Hatano and J Davis
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 677-682;

  2. Johnson, N

    1. Irreversible opiate agonists and antagonists. III. Phenylhydrazone derivatives of naloxone and oxymorphone.
      E F Hahn, Y Itzhak, S Nishimura, N Johnson and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 846-850;

  3. Johnson, R D

    1. Thyroid status and adrenergic receptor subtypes in the rat: comparison of receptor density and responsiveness.
      A W Fox, E N Juberg, J M May, R D Johnson, P W Abel and K P Minneman
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 715-723;

  4. Josepovitz, C

    1. Effect of netilmicin on the phospholipid composition of subcellular fractions of rat renal cortex.
      C Josepovitz, T Farruggella, R Levine, B Lane and G J Kaloyanides
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 810-819;

  5. Juberg, E N

    1. Thyroid status and adrenergic receptor subtypes in the rat: comparison of receptor density and responsiveness.
      A W Fox, E N Juberg, J M May, R D Johnson, P W Abel and K P Minneman
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 715-723;

K

  1. Kajiwara, A

    1. Potent excitatory effect of scaritoxin on the guinea-pig vas deferens, taenia caeci and ileum.
      M Tatsumi, A Kajiwara, T Yasumoto and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 783-787;

  2. Kaloyanides, G J

    1. Effect of netilmicin on the phospholipid composition of subcellular fractions of rat renal cortex.
      C Josepovitz, T Farruggella, R Levine, B Lane and G J Kaloyanides
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 810-819;

  3. Katzman, N J

    1. Differential diazepam-antagonist effects of the benzodiazepine receptor ligand CGS 9895 in rodents.
      N J Katzman and H E Shannon
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 589-595;

  4. Kimura, T

    1. Predominance of postsynaptic mechanism in vagal suppression of sympathetic tachycardia in the dog.
      T Kimura, W Uchida and S Satoh
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 793-797;

  5. Kochel, P J

    1. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
      D E Mais, R M Burch, D L Saussy, P J Kochel and P V Halushka
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 729-734;

  6. Kopaciewicz, L J

    1. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
      R J Shebuski, T Fujita, J M Smith, L J Kopaciewicz, A L Blumberg and J P Hieble
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 735-740;

  7. Kubo, T

    1. Presynaptic inhibitory dopamine receptors on noradrenergic nerve terminals: analysis of biphasic actions of dopamine and apomorphine on the release of endogenous norepinephrine in rat hypothalamic slices.
      Y Misu, Y Goshima, H Ueda and T Kubo
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 771-777;

  8. Kuriyama, H

    1. Mechanisms of the bepridil-induced vasodilation of the rabbit mesenteric artery.
      H Suzuki, T Itoh and H Kuriyama
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 749-756;
    2. Eperisone, an antispastic agent, possesses vasodilating actions on the guinea-pig basilar artery.
      M Fujioka and H Kuriyama
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 757-763;
    3. Effects of YM-12617, an alpha adrenoceptor blocking agent, on electrical and mechanical properties of the guinea-pig mesenteric and pulmonary arteries.
      K Fujii and H Kuriyama
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 764-770;

L

  1. Lane, B

    1. Effect of netilmicin on the phospholipid composition of subcellular fractions of rat renal cortex.
      C Josepovitz, T Farruggella, R Levine, B Lane and G J Kaloyanides
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 810-819;

  2. Lappe, R W

    1. Graded regional vasodilation with converting enzyme inhibitors in conscious spontaneously hypertensive rats.
      R W Lappe, J A Todt and R L Wendt
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 651-656;

  3. Lash, L H

    1. Nephrotoxicity of S-(2-chloro-1,1,2-trifluoroethyl)glutathione and S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine, the glutathione and cysteine conjugates of chlorotrifluoroethene.
      D R Dohn, J R Leininger, L H Lash, A J Quebbemann and M W Anders
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 851-857;

  4. Lauterburg, B H

    1. Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans.
      B H Lauterburg, C V Smith, E L Todd and J R Mitchell
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 566-570;

  5. Leininger, J R

    1. Nephrotoxicity of S-(2-chloro-1,1,2-trifluoroethyl)glutathione and S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine, the glutathione and cysteine conjugates of chlorotrifluoroethene.
      D R Dohn, J R Leininger, L H Lash, A J Quebbemann and M W Anders
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 851-857;

  6. Leventer, S M

    1. Regional differences in ethylcholine mustard aziridinium ion (AF64A)-induced deficits in presynaptic cholinergic markers for the rat central nervous system.
      T W Vickroy, M Watson, S M Leventer, W R Roeske, I Hanin and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 577-582;

  7. Levine, R

    1. Effect of netilmicin on the phospholipid composition of subcellular fractions of rat renal cortex.
      C Josepovitz, T Farruggella, R Levine, B Lane and G J Kaloyanides
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 810-819;

  8. Lhoste, F

    1. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
      I Cavero, J Lorrain, E D Di Paola, F Lhoste, B Payen, T Dennis and B Scatton
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 798-809;

  9. Liang, C S

    1. Beta adrenergic-mediated vasodilator response to insulin in the human forearm.
      M A Creager, C S Liang and J D Coffman
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 709-714;

  10. Lorrain, J

    1. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
      I Cavero, J Lorrain, E D Di Paola, F Lhoste, B Payen, T Dennis and B Scatton
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 798-809;

M

  1. Mais, D E

    1. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
      D E Mais, R M Burch, D L Saussy, P J Kochel and P V Halushka
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 729-734;

  2. Marks, M J

    1. Time course study of the effects of chronic nicotine infusion on drug response and brain receptors.
      M J Marks, J A Stitzel and A C Collins
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 619-628;

  3. May, J M

    1. Thyroid status and adrenergic receptor subtypes in the rat: comparison of receptor density and responsiveness.
      A W Fox, E N Juberg, J M May, R D Johnson, P W Abel and K P Minneman
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 715-723;

  4. Messick, K

    1. Effects of dopamine, (+/-)-dobutamine and the (+)- and (-)-enantiomers of dobutamine on cardiac function in pithed rats.
      R R Ruffolo and K Messick
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 558-565;

  5. Minneman, K P

    1. Thyroid status and adrenergic receptor subtypes in the rat: comparison of receptor density and responsiveness.
      A W Fox, E N Juberg, J M May, R D Johnson, P W Abel and K P Minneman
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 715-723;

  6. Misu, Y

    1. Presynaptic inhibitory dopamine receptors on noradrenergic nerve terminals: analysis of biphasic actions of dopamine and apomorphine on the release of endogenous norepinephrine in rat hypothalamic slices.
      Y Misu, Y Goshima, H Ueda and T Kubo
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 771-777;

  7. Mitchell, J R

    1. Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans.
      B H Lauterburg, C V Smith, E L Todd and J R Mitchell
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 566-570;

  8. Molinoff, P B

    1. Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists.
      K A Neve, D A Barrett and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 657-664;

N

  1. Namath, I J

    1. Comparative cardiorespiratory effects produced by taurine and glycine applied to the ventral surface of the medulla.
      P J Gatti, J D Souza, I J Namath, A M Da Silva, J R Holtman and R Gillis
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 820-828;

  2. Nash, C B

    1. Effect of an aminocardenolide and digoxin upon atrioventricular refractory period in the dog.
      R W Caldwell and C B Nash
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 583-588;

  3. Neve, K A

    1. Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists.
      K A Neve, D A Barrett and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 657-664;

  4. Nievelstein, H M

    1. Effects of the renal vasodilator prodrug CGP 22 979A and its parent compound CGP 18 137A on renal and central hemodynamics in conscious spontaneously hypertensive rats.
      H M Nievelstein, H van Essen, R Hornsveld, H A Struyker-Boudier and J F Smits
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 778-782;

  5. Nishibori, M

    1. Phencyclidine and the dynamics of mouse brain histamine.
      Y Itoh, R Oishi, M Nishibori and K Saeki
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 788-792;

  6. Nishimura, S

    1. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
      E F Hahn, S Nishimura, R R Goodman and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 839-845;
    2. Irreversible opiate agonists and antagonists. III. Phenylhydrazone derivatives of naloxone and oxymorphone.
      E F Hahn, Y Itzhak, S Nishimura, N Johnson and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 846-850;

  7. Nunan, L

    1. Proenkephalin A fragments exhibit spinal and supraspinal opioid activity in vivo.
      A Dray, L Nunan and W Wire
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 670-676;

O

  1. Ohizumi, Y

    1. Potent excitatory effect of scaritoxin on the guinea-pig vas deferens, taenia caeci and ileum.
      M Tatsumi, A Kajiwara, T Yasumoto and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 783-787;

  2. Oishi, R

    1. Phencyclidine and the dynamics of mouse brain histamine.
      Y Itoh, R Oishi, M Nishibori and K Saeki
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 788-792;

  3. Okita, G T

    1. Inhibition of electrogenic Na-pumping attributable to binding of cardiac steroids to high-affinity pump sites in human atrium.
      H H Rasmussen, R E Ten Eick, G T Okita, R S Hartz and D H Singer
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 629-635;

P

  1. Pasternak, G W

    1. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
      E F Hahn, S Nishimura, R R Goodman and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 839-845;
    2. Irreversible opiate agonists and antagonists. III. Phenylhydrazone derivatives of naloxone and oxymorphone.
      E F Hahn, Y Itzhak, S Nishimura, N Johnson and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 846-850;

  2. Payen, B

    1. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
      I Cavero, J Lorrain, E D Di Paola, F Lhoste, B Payen, T Dennis and B Scatton
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 798-809;

  3. Payne, A J

    1. Effect of a new hypoglycemic agent (MDL-310) on glucose metabolism.
      K M Robinson, A J Payne, S L Zehr and B L Rhinehart
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 571-576;

  4. Pettibone, D J

    1. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
      B V Clineschmidt, D R Reiss, D J Pettibone and J L Robinson
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 696-708;

Q

  1. Quebbemann, A J

    1. Nephrotoxicity of S-(2-chloro-1,1,2-trifluoroethyl)glutathione and S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine, the glutathione and cysteine conjugates of chlorotrifluoroethene.
      D R Dohn, J R Leininger, L H Lash, A J Quebbemann and M W Anders
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 851-857;

R

  1. Raffa, R B

    1. Measurement of thermodynamic parameters for norepinephrine contraction of isolated rabbit thoracic aorta.
      R B Raffa, J F Aceto and R J Tallarida
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 596-600;

  2. Rasmussen, H H

    1. Inhibition of electrogenic Na-pumping attributable to binding of cardiac steroids to high-affinity pump sites in human atrium.
      H H Rasmussen, R E Ten Eick, G T Okita, R S Hartz and D H Singer
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 629-635;

  3. Reisine, T

    1. Pertussis toxin blocks somatostatin inhibition of calcium mobilization and reduces the affinity of somatostatin receptors for agonists.
      T Reisine and S Guild
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 551-557;

  4. Reiss, D R

    1. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
      B V Clineschmidt, D R Reiss, D J Pettibone and J L Robinson
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 696-708;

  5. Rhinehart, B L

    1. Effect of a new hypoglycemic agent (MDL-310) on glucose metabolism.
      K M Robinson, A J Payne, S L Zehr and B L Rhinehart
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 571-576;

  6. Riker, W F

    1. Pharmacologic excitability of rat motor nerve endings: the effect of adrenalectomy on neostigmine-induced fasciculations.
      J S Sprouse, T Baker and W F Riker
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 864-872;

  7. Robinson, J L

    1. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
      B V Clineschmidt, D R Reiss, D J Pettibone and J L Robinson
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 696-708;

  8. Robinson, K M

    1. Effect of a new hypoglycemic agent (MDL-310) on glucose metabolism.
      K M Robinson, A J Payne, S L Zehr and B L Rhinehart
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 571-576;

  9. Roeske, W R

    1. Regional differences in ethylcholine mustard aziridinium ion (AF64A)-induced deficits in presynaptic cholinergic markers for the rat central nervous system.
      T W Vickroy, M Watson, S M Leventer, W R Roeske, I Hanin and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 577-582;
    2. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart.
      R A Evans, M Watson, H I Yamamura and W R Roeske
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 612-618;

  10. Ruffolo, R R

    1. Effects of dopamine, (+/-)-dobutamine and the (+)- and (-)-enantiomers of dobutamine on cardiac function in pithed rats.
      R R Ruffolo and K Messick
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 558-565;
    2. Relationship between alpha adrenoceptor occupancy and response for the alpha-1 adrenoceptor agonist, cirazoline, and the alpha-2 adrenoceptor agonist, B-HT 933, in canine saphenous vein.
      R R Ruffolo and R L Zeid
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 636-643;

S

  1. Saeki, K

    1. Phencyclidine and the dynamics of mouse brain histamine.
      Y Itoh, R Oishi, M Nishibori and K Saeki
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 788-792;

  2. Sanders, K M

    1. Effects of ethyl alcohol on phasic and tonic contractions of the proximal stomach.
      K M Sanders and R G Berry
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 858-863;

  3. Satoh, S

    1. Predominance of postsynaptic mechanism in vagal suppression of sympathetic tachycardia in the dog.
      T Kimura, W Uchida and S Satoh
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 793-797;

  4. Saussy, D L

    1. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
      D E Mais, R M Burch, D L Saussy, P J Kochel and P V Halushka
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 729-734;

  5. Sawicki, G J

    1. Electrophysiologic actions and interactions between lysophosphatidylcholine and lidocaine in the nonsteady state: the match between multiphasic arrhythmogenic mechanisms and multiple drug effects in cardiac Purkinje fibers.
      G J Sawicki and M F Arnsdorf
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 829-838;

  6. Scatton, B

    1. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
      I Cavero, J Lorrain, E D Di Paola, F Lhoste, B Payen, T Dennis and B Scatton
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 798-809;

  7. Schofield, T L

    1. Blockade of endothelium-dependent relaxation by the amiloride analog dichlorobenzamil: possible role of Na+/Ca++ exchange in the release of endothelium-derived relaxant factor.
      R J Winquist, P B Bunting and T L Schofield
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 644-650;

  8. Schuster, C R

    1. Acute tolerance development to the cardiovascular and subjective effects of cocaine.
      M W Fischman, C R Schuster, J Javaid, Y Hatano and J Davis
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 677-682;

  9. Shannon, H E

    1. Differential diazepam-antagonist effects of the benzodiazepine receptor ligand CGS 9895 in rodents.
      N J Katzman and H E Shannon
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 589-595;

  10. Shebuski, R J

    1. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
      R J Shebuski, T Fujita, J M Smith, L J Kopaciewicz, A L Blumberg and J P Hieble
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 735-740;

  11. Silkworth, J B

    1. Relationship between Ah receptor-mediated polychlorinated biphenyl (PCB)-induced humoral immunosuppression and thymic atrophy.
      J B Silkworth and L Antrim
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 606-611;

  12. Simasko, S M

    1. Structure-activity relationship for substance P inhibition of carbamylcholine-stimulated 22Na+ flux in neuronal (PC12) and non-neuronal (BC3H1) cell lines.
      S M Simasko, J R Soares and G A Weiland
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 601-605;

  13. Singer, D H

    1. Inhibition of electrogenic Na-pumping attributable to binding of cardiac steroids to high-affinity pump sites in human atrium.
      H H Rasmussen, R E Ten Eick, G T Okita, R S Hartz and D H Singer
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 629-635;

  14. Smith, C V

    1. Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans.
      B H Lauterburg, C V Smith, E L Todd and J R Mitchell
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 566-570;

  15. Smith, J M

    1. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
      R J Shebuski, T Fujita, J M Smith, L J Kopaciewicz, A L Blumberg and J P Hieble
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 735-740;

  16. Smits, J F

    1. Effects of the renal vasodilator prodrug CGP 22 979A and its parent compound CGP 18 137A on renal and central hemodynamics in conscious spontaneously hypertensive rats.
      H M Nievelstein, H van Essen, R Hornsveld, H A Struyker-Boudier and J F Smits
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 778-782;

  17. Snape, W J

    1. Effect of amino acids on isolated colonic smooth muscle from the rabbit.
      W J Snape and S Yoo
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 690-695;

  18. Soares, J R

    1. Structure-activity relationship for substance P inhibition of carbamylcholine-stimulated 22Na+ flux in neuronal (PC12) and non-neuronal (BC3H1) cell lines.
      S M Simasko, J R Soares and G A Weiland
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 601-605;

  19. Souza, J D

    1. Comparative cardiorespiratory effects produced by taurine and glycine applied to the ventral surface of the medulla.
      P J Gatti, J D Souza, I J Namath, A M Da Silva, J R Holtman and R Gillis
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 820-828;

  20. Spealman, R D

    1. Modulation of the behavioral effects of chlordiazepoxide by methylxanthines and analogs of adenosine in squirrel monkeys.
      V L Coffin and R D Spealman
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 724-728;

  21. Sprouse, J S

    1. Pharmacologic excitability of rat motor nerve endings: the effect of adrenalectomy on neostigmine-induced fasciculations.
      J S Sprouse, T Baker and W F Riker
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 864-872;

  22. Stitzel, J A

    1. Time course study of the effects of chronic nicotine infusion on drug response and brain receptors.
      M J Marks, J A Stitzel and A C Collins
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 619-628;

  23. Struyker-Boudier, H A

    1. Effects of the renal vasodilator prodrug CGP 22 979A and its parent compound CGP 18 137A on renal and central hemodynamics in conscious spontaneously hypertensive rats.
      H M Nievelstein, H van Essen, R Hornsveld, H A Struyker-Boudier and J F Smits
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 778-782;

  24. Suzuki, H

    1. Mechanisms of the bepridil-induced vasodilation of the rabbit mesenteric artery.
      H Suzuki, T Itoh and H Kuriyama
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 749-756;

T

  1. Tallarida, R J

    1. Measurement of thermodynamic parameters for norepinephrine contraction of isolated rabbit thoracic aorta.
      R B Raffa, J F Aceto and R J Tallarida
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 596-600;

  2. Tatsumi, M

    1. Potent excitatory effect of scaritoxin on the guinea-pig vas deferens, taenia caeci and ileum.
      M Tatsumi, A Kajiwara, T Yasumoto and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 783-787;

  3. Ten Eick, R E

    1. Inhibition of electrogenic Na-pumping attributable to binding of cardiac steroids to high-affinity pump sites in human atrium.
      H H Rasmussen, R E Ten Eick, G T Okita, R S Hartz and D H Singer
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 629-635;

  4. Thomas, D J

    1. Use of 2,3-dimercaptopropane-1-sulfonate in treatment of lead poisoning in children.
      J J Chisolm and D J Thomas
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 665-669;

  5. Todd, E L

    1. Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans.
      B H Lauterburg, C V Smith, E L Todd and J R Mitchell
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 566-570;

  6. Todt, J A

    1. Graded regional vasodilation with converting enzyme inhibitors in conscious spontaneously hypertensive rats.
      R W Lappe, J A Todt and R L Wendt
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 651-656;

U

  1. Uchida, W

    1. Predominance of postsynaptic mechanism in vagal suppression of sympathetic tachycardia in the dog.
      T Kimura, W Uchida and S Satoh
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 793-797;

  2. Ueda, H

    1. Presynaptic inhibitory dopamine receptors on noradrenergic nerve terminals: analysis of biphasic actions of dopamine and apomorphine on the release of endogenous norepinephrine in rat hypothalamic slices.
      Y Misu, Y Goshima, H Ueda and T Kubo
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 771-777;

V

  1. van Essen, H

    1. Effects of the renal vasodilator prodrug CGP 22 979A and its parent compound CGP 18 137A on renal and central hemodynamics in conscious spontaneously hypertensive rats.
      H M Nievelstein, H van Essen, R Hornsveld, H A Struyker-Boudier and J F Smits
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 778-782;

  2. Vickroy, T W

    1. Regional differences in ethylcholine mustard aziridinium ion (AF64A)-induced deficits in presynaptic cholinergic markers for the rat central nervous system.
      T W Vickroy, M Watson, S M Leventer, W R Roeske, I Hanin and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 577-582;

W

  1. Watson, M

    1. Regional differences in ethylcholine mustard aziridinium ion (AF64A)-induced deficits in presynaptic cholinergic markers for the rat central nervous system.
      T W Vickroy, M Watson, S M Leventer, W R Roeske, I Hanin and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 577-582;
    2. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart.
      R A Evans, M Watson, H I Yamamura and W R Roeske
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 612-618;

  2. Weiland, G A

    1. Structure-activity relationship for substance P inhibition of carbamylcholine-stimulated 22Na+ flux in neuronal (PC12) and non-neuronal (BC3H1) cell lines.
      S M Simasko, J R Soares and G A Weiland
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 601-605;

  3. Wendt, R L

    1. Graded regional vasodilation with converting enzyme inhibitors in conscious spontaneously hypertensive rats.
      R W Lappe, J A Todt and R L Wendt
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 651-656;

  4. Winquist, R J

    1. Blockade of endothelium-dependent relaxation by the amiloride analog dichlorobenzamil: possible role of Na+/Ca++ exchange in the release of endothelium-derived relaxant factor.
      R J Winquist, P B Bunting and T L Schofield
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 644-650;

  5. Wire, W

    1. Proenkephalin A fragments exhibit spinal and supraspinal opioid activity in vivo.
      A Dray, L Nunan and W Wire
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 670-676;

Y

  1. Yamamura, H I

    1. Regional differences in ethylcholine mustard aziridinium ion (AF64A)-induced deficits in presynaptic cholinergic markers for the rat central nervous system.
      T W Vickroy, M Watson, S M Leventer, W R Roeske, I Hanin and H I Yamamura
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 577-582;
    2. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart.
      R A Evans, M Watson, H I Yamamura and W R Roeske
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 612-618;

  2. Yasumoto, T

    1. Potent excitatory effect of scaritoxin on the guinea-pig vas deferens, taenia caeci and ileum.
      M Tatsumi, A Kajiwara, T Yasumoto and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 783-787;

  3. Yeh, S Y

    1. Potentiation of pentazocine antinociception by tripelennamine in the rat.
      S Y Yeh
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 683-689;

  4. Yoo, S

    1. Effect of amino acids on isolated colonic smooth muscle from the rabbit.
      W J Snape and S Yoo
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 690-695;

Z

  1. Zehr, S L

    1. Effect of a new hypoglycemic agent (MDL-310) on glucose metabolism.
      K M Robinson, A J Payne, S L Zehr and B L Rhinehart
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 571-576;

  2. Zeid, R L

    1. Relationship between alpha adrenoceptor occupancy and response for the alpha-1 adrenoceptor agonist, cirazoline, and the alpha-2 adrenoceptor agonist, B-HT 933, in canine saphenous vein.
      R R Ruffolo and R L Zeid
      Journal of Pharmacology and Experimental Therapeutics December 1985, 235 (3) 636-643;
Back to top

In this issue

Advertisement